Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease
Roberto Diletti(Erasmus MC), Robert‐Jan van Geuns(Erasmus MC), Nienke van Ditzhuijzen(Erasmus MC), Mattie Lenzen, Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Marco Valgimigli(University of Bern), Jürgen Ligthart(Erasmus MC), Patrick W. Serruys(Erasmus MC), Jiang Ming Fam(Duke-NUS Medical School), Felix Zijlstra(Erasmus MC), Peter P. de Jaegere(Erasmus MC), Yuki Ishibashi(Erasmus University Rotterdam), Shimpei Nakatani(Erasmus MC), Nicolas M. Van Mieghem(Erasmus MC), Eveliyn Regar(Erasmus MC), Cordula Felix(Erasmus University Rotterdam)
Cited by 0
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k